Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1 to 25 of 1848

TitleReference numberPublishedLast updated
3C Patch for treating diabetic foot ulcersMTG66
Ab externo canaloplasty for primary open-angle glaucomaIPG591
Ab interno canaloplasty for open-angle glaucomaIPG745
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)TA568
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritisTA373
Abdominal aortic aneurysm: diagnosis and managementNG156
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA563
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrenceTA810
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA725
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA387
Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancerTA721
Abortion careNG140
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisTA814
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Acne vulgaris: managementNG198
Acute coronary syndromesNG185
Acute heart failure: diagnosis and managementCG187
Acute kidney injury: prevention, detection and managementNG148
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Acutely ill adults in hospital: recognising and responding to deteriorationCG50
Adalimumab and dexamethasone for treating non-infectious uveitisTA460
Adalimumab for the treatment of adults with psoriasisTA146
Adalimumab for treating moderate to severe hidradenitis suppurativaTA392
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopleTA455

Results per page

  1. 10
  2. 25
  3. 50
  4. All